Arcellx (ACLX) FCF Margin (2023 - 2025)
Arcellx's quarterly FCF Margin came in at 3627.75% in Q4 2025, down 324697.0% year-on-year from N/an in Q4 2024, and down 266.98% quarter-over-quarter from 988.55% in Q3 2025.
Arcellx has reported FCF Margin for 3 years, with the latest figure at 3627.75% in Q4 2025.
- For the quarter ending Q4 2025, FCF Margin fell 324697.0% year-over-year to 3627.75%; the trailing twelve-month figure through Dec 2025 stood at 954.02% (down 86425.0% YoY), and the FY2025 full-year result was 953.89%, down 86412.0% from the prior year.
- FCF Margin for Q4 2025 stood at 3627.75%, down from 988.55% in the prior quarter.
- The five-year high for FCF Margin was 1001.19% in Q1 2023, with the low at 3627.75% in Q4 2025.
- Average FCF Margin over 3 years is 466.28%, with a median of 177.5% recorded in 2024.
- Year-over-year, FCF Margin soared 21078 bps in 2024 and sank 324697 bps in 2025.
- Tracing ACLX's FCF Margin over 3 years: stood at 69.72% in 2023, then plunged by 646 bps to 380.78% in 2024, then sank by 853 bps to 3627.75% in 2025.
- The last three FCF Margin figures came in at 3627.75% (Q4 2025), 988.55% (Q3 2025), and 529.18% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | -3,627.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3,627.75% |
| Sep 30, 2025 | -988.55% |
| Jun 30, 2025 | -529.18% |
| Mar 31, 2025 | -786.38% |
| Dec 31, 2024 | -380.78% |
| Sep 30, 2024 | 149.94% |
| Jun 30, 2024 | -158.43% |
| Mar 31, 2024 | -87.67% |
| Dec 31, 2023 | 69.72% |
| Sep 30, 2023 | -60.84% |
| Jun 30, 2023 | -196.57% |
| Mar 31, 2023 | 1,001.19% |